Indoco Remedies (INDOCO) Share Price Rises 10.44% as Stock Gains Today
- September 2, 2026
- Posted by: Kunal Singla
- Category: News
Indoco Remedies Share Price is trading at Rs 248.05, up Rs 23.45 or 10.44% from the previous close of Rs 224.60. The company’s market capitalisation stands at Rs 2,094.71 crore, placing the move in a clear market-cap context for investors tracking Indoco Remedies Share Price Today. As of 18 November 2026 at 9:23:16 AM IST, the stock is among the top gainer names in the Indian stock market session so far.
Univest data confirms the move itself, though no company-specific trigger has been identified. That makes this Indoco Remedies Share Price move relevant mainly as a price action story, with the next layer of analysis coming from valuation, profitability, sector benchmarking and peer comparison. For readers scanning Indoco Remedies Stock News or Indoco Remedies Share Price News, the key question is whether the current valuation and operating metrics justify the market’s latest pricing. Univest data also shows that the stock opened at Rs 226.75, touched a high of Rs 248.80 and a low of Rs 226.75 so far today.
Indoco Remedies Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 248.05 |
| Previous Close | Rs 224.6 |
| Today's Move | Rs 23.45 (+10.44%) |
| Open | Rs 226.75 |
| High | Rs 248.8 |
| Low | Rs 226.75 |
| Market Capitalisation | Rs 2,094.71 crore |
| Market Cap Category | Small Cap |
Indoco Remedies Ltd. (INDOCO) rose to Rs 248.05 from the previous close of Rs 224.6, a move of Rs 23.45 or 10.44%. The stock opened at Rs 226.75, reached a high of Rs 248.8, recorded a low of Rs 226.75.
Indoco Remedies Share Price Today shows a sharp intraday rise of Rs 23.45 over the previous close, with the stock moving from Rs 226.75 at the open to Rs 248.80 at the day high. The low for the day was Rs 226.75, so the current price is near the upper end of the day’s range.
This Indoco Remedies Share Price action indicates a strong same-day move in the stock, but the verified numbers stop at the price itself. The move is best read as a market event first and a thesis second. For anyone following Indoco Remedies Share Price Live updates, the current level of Rs 248.05 is materially above the previous close and has kept Indoco Remedies Stock Gaining Today on the radar. Univest data confirms the move, while the reason remains unconfirmed. From here, the more useful question is whether the move aligns with the company’s financial profile and sector valuation backdrop, which is where Indoco Remedies Fundamental Analysis becomes important.
Indoco Remedies Ltd. (INDOCO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,094.71 crore |
| P/E Ratio | 64.92x |
| P/B Ratio | 2.03x |
| ROE | -10.13% |
| ROCE | 0.79% |
| EPS | Rs 3.46 |
| Book Value Per Share | Rs 110.65 |
| Dividend Yield | 0.09% |
Indoco Remedies Ltd. (INDOCO) fundamental metrics show P/E 64.92x, P/B 2.03x, ROE -10.13%, ROCE 0.79%. Read together, these ratios describe the company’s position rather than a recommendation.
Indoco Remedies Ltd. has a market capitalisation of Rs 2,094.71 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 64.92x, P/B at 2.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -10.13% and ROCE of 0.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.46, book value per share of Rs 110.65, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 64.92x |
| Benchmark Median P/E | 31.01x |
| Benchmark Average P/E | 58.7x |
| Benchmark P/E Range | 2.75x to 1,425.63x |
| Company P/B Ratio | 2.03x |
| Benchmark Median P/B | 2.88x |
| Company ROE | -10.13% |
| Benchmark Median ROE | 11.33% |
| Company ROCE | 0.79% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 2,094.71 crore |
| Benchmark Median Market Cap | Rs 791.38 crore |
Indoco Remedies Ltd. (INDOCO) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Indoco Remedies Ltd. (INDOCO) has a P/E ratio of 64.92x, which is above the benchmark median of 31.01x, a difference of +109.35%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Indoco Remedies Ltd. (INDOCO) has a ROE of -10.13%, which is below the benchmark median of 11.33%, a difference of -189.41%. Indoco Remedies Ltd. (INDOCO) has a ROCE of 0.79%, which is below the benchmark median of 13.1%, a difference of -93.97%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,47,943.84 | 40.92 | 5.03 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,94,962.14 | 87.74 | 16.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,78,390.62 | 83.65 | 9.67 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,19,789.92 | 94.36 | 20.86 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,603.21 | 28.7 | 4.31 | 19.69 | 21.39 |
Indoco Remedies Ltd. (INDOCO) has a P/E ratio of 64.92x compared with the displayed peer median of 83.65x. Peer multiples give relative context only, not a buy or sell view. Its ROE of -10.13% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 0.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Indoco Remedies Ltd. (INDOCO) has a market capitalisation of Rs 2,094.71 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Indoco Remedies
- Indoco Remedies Share Price is up 10.44% today, with the stock trading at Rs 248.05 versus the previous close of Rs 224.60.
- The move is visible in price action alone, because according to Univest data no company-specific catalyst is established.
- Indoco Remedies Fundamental Analysis shows P/E of 64.92, P/B of 2.03, EPS of 3.46 and book value of Rs 110.65 per share.
- ROE of -10.13% and ROCE of 0.79% keep the Indoco Remedies Share Price conversation tied to profitability and capital efficiency.
- The Healthcare sector and Pharmaceuticals & Drugs industry context shows the stock trading above the sector median P/E but below the sector median P/B.
About Indoco Remedies Ltd.
Indoco Remedies Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company works in pharmaceuticals, so its business is linked to drug development, manufacturing and related healthcare products within the broader medicine ecosystem. For readers following Indoco Remedies Share Price, the company profile matters because the stock is being assessed not only on daily moves but also on financial performance and sector positioning.
The latest Univest figures place the company at a market capitalisation of Rs 2,094.71 crore. Its current valuation metrics include a P/E ratio of 64.92 and a P/B ratio of 2.03, while EPS is 3.46 and book value per share is Rs 110.65. Dividend yield is 0.09%. These numbers give a compact view of the business from a market perspective and help frame Indoco Remedies Share Price Today within both company-specific and industry-specific context. For anyone scanning Indoco Remedies Company News, that combination of market value, valuation and return metrics is the core profile to watch.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Indoco Remedies Share Price rising today?
Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. Indoco Remedies Share Price is up 10.44% at Rs 248.05, with the previous close at Rs 224.60 and market capitalisation at Rs 2,094.71 crore.
What is Indoco Remedies Share Price today?
Ans. Indoco Remedies Share Price is Rs 248.05 as of 18 November 2026 at 9:23:16 AM IST. The stock is higher by Rs 23.45, or 10.44%, from the previous close of Rs 224.60.
What is the market capitalisation of Indoco Remedies?
Ans. The market capitalisation is Rs 2,094.71 crore. In Indoco Remedies Share Price terms, that makes the company larger than the sector median market cap of Rs 791.38 crore, though still well below the biggest healthcare peers.
How does Indoco Remedies Share Price compare on valuation?
Ans. Indoco Remedies Share Price carries a P/E ratio of 64.92 and a P/B ratio of 2.03. The P/E is above the sector median of 31.01, while the P/B is below the sector median of 2.88.
What do ROE and ROCE show for Indoco Remedies Share Price?
Ans. ROE is -10.13% and ROCE is 0.79%. For Indoco Remedies Share Price, those return metrics are weaker than the sector median and the peer set shown in the same industry comparison.
What is the EPS and book value for Indoco Remedies?
Ans. EPS is 3.46 and book value per share is Rs 110.65. These figures help frame Indoco Remedies Share Price because they show earnings per share and the accounting value behind each share.
Is dividend yield meaningful in Indoco Remedies Share Price analysis?
Ans. Dividend yield is 0.09%, which is a small historical payout indicator. For Indoco Remedies Share Price, it adds income context, but the stock’s current story is being driven more by price action and valuation metrics.
Track Indoco Remedies Share Price on Univest
Use Indoco Remedies Ltd. (INDOCO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Indoco Remedies Share Price can be tracked on Univest for live updates, valuation ratios, 52-week levels and market insights. Readers can follow Indoco Remedies Share Price Today, compare it with sector benchmarks and review financial ratios in one place. Univest also helps users keep an eye on Indoco Remedies Stock News, Indoco Remedies Latest News and broader Indoco Remedies Stock Analysis without leaving the stock page.